2,229,244 Shares in CVS Health Corporation $CVS Acquired by Canada Pension Plan Investment Board

Key Points

• Canada Pension Plan Investment Board acquired 2.23 million CVS Health shares worth approximately $230.6 million, representing about 0.17% of the company. Institutional investors collectively own 80.66% of CVS stock.
• CVS reported quarterly earnings of $2.58 per share, beating expectations of $1.87, while revenue rose 7.3% year over year to $106.1 billion. The company reaffirmed fiscal 2026 EPS guidance of $7.90–$8.10.
• Analysts maintain a favorable outlook, with 22 Buy ratings and two Holds, a “Moderate Buy” consensus, and an average price target of $107.17. CVS also pays a quarterly dividend of $0.665, equivalent to a 2.9% annual yield.

Canada Pension Plan Investment Board bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,229,244 shares of the pharmacy operator's stock, valued at approximately $230,615,000. Canada Pension Plan Investment Board owned about 0.17% of CVS Health at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CVS. Parkman Healthcare Partners LLC purchased a new position in CVS Health in the 2nd quarter worth $40,531,000. Legal & General Group Plc purchased a new stake in CVS Health during the 2nd quarter valued at about $948,947,000. The Manufacturers Life Insurance Company acquired a new position in shares of CVS Health in the second quarter valued at about $133,186,000. Jones Financial Companies Lllp purchased a new position in shares of CVS Health in the second quarter worth about $383,000. Finally, Van Hulzen Asset Management LLC purchased a new position in shares of CVS Health in the second quarter worth about $357,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Price Performance

NYSE:CVS opened at $92.95 on Wednesday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The stock's 50-day moving average price is $101.73 and its 200-day moving average price is $89.20. The stock has a market capitalization of $118.88 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 0.86 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. During the same quarter in the prior year, the firm posted $1.81 EPS. CVS Health's quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health's dividend payout ratio (DPR) is currently 70.37%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Wells Fargo & Company upped their target price on CVS Health from $103.00 to $123.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Truist Financial lifted their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CVS Health from $88.00 to $92.00 and gave the company a "buy" rating in a report on Thursday, May 7th. Royal Bank Of Canada raised their target price on shares of CVS Health from $107.00 to $113.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Finally, JPMorgan Chase & Co. boosted their target price on shares of CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source